Meaningful Use Certified Reports

This EHR Module is 2014 Edition compliant and has been certified by an ONC-ACB in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services.  In addition, Azara DRVS supports meaningful use reporting via specialized registry, which enables eligible providers (EPs) to complete the stage 2, and newly released stage 3 reporting requirements.  Specialized registry reporting may provide many EPs with a menu option that is more aligned with their scope of practice.

This certification does not represent an endorsement by the U.S. Department of Health and Human Services.

Certified EHR Vendor & Product Information

Vendor/Developer Name: Azara Healthcare, LLC
Certified EHR Name: Azara DRVS with Azara DRVS CQM (1.0)
Certified EHR Version: Azara DRVS 3.6.1 with Azara DRVS CQM 1.0
InfoGard Certification #: IG-3114-13-0043
Certification Date: December 23, 2013
Certification Criteria:
  • 314(c) (1) Clinical Quality Measures – Capture & Export
  • 314(c) (2) Clinical Quality Measures – Import and Calculate
  • 314(c) (3) Clinical Quality Measures – Electronic Submission
  • 314(g) (4) Quality Management System
Clinical Quality Measures: See List Below
Additional SW Required: DRVS is a reporting and analytics platform, we require the user to have a Certified EHR for collecting and recording all items that are reported.

 


Certified EHR Vendor & Product Information

 Vendor/Developer Name: Azara Healthcare, LLC
Certified EHR Name: Azara DRVS Immunizations
Certified EHR Version: Azara DRVS Immunizations (1.0)
InfoGard Certification #: IG-3114-15-0028
Certification Date: May 19, 2015
Certification Criteria:
  • 314 (f) (2) Transmission to Immunization Registries
  • 314 (g) (4) Quality Management System
Clinical Quality Measures: NA

Additional SW Required:
In addition, Mirth is required for DRVS to transmit data to Immunization Registries.

 


III. Transparency and Disclosures

In order to use Azara DRVS for Meaningful Use, all users must complete an Azara DRVS Implementation, which will connect the the provider’s Certified EHR to the Azara DRVS Data Warehouse.  Without this implementation, Azara will not have the necessary data to calculate the reported measures.  The costs of the Azara DRVS Implementation are required as part of the initial Azara DRVS startup fees.

Azara’s ability to calculate any specific measure is subject to the source EHR system collecting and storing the data elements necessary to calculate the particular measure.  If the data is not extractable from the source system in a STRUCTURED format, Azara cannot accurately calculate Meaningful Use Measures.  In addition, some EHR vendors may charge additional fees for access to their EHR and/or for them to send data to Azara.

Azara does offer additional add-on modules for referral reporting which is subject to additional costs.  The referral module is not required for any of Azara’s certified reporting elements.

There are no contractual limitations to the software that would impeded a users ability to operate the Certified Technology.


 Azara Meaningful Use Support

Our tools support Community Health Center initiatives to meet federal criteria for Meaningful Use and receive its associated technology reimbursements.

Azara’s certification includes 25 of the 64 2014 Edition Clinical Quality Measures (CQMs) and prioritizes those measures which are most relevant for primary care, care coordination, and performance tracking.

The clinical quality measures to which Azara DRVS has been certified include:

Measure CMS ID NQF ID
Controlling High Blood Pressure CMS165v2 0018
Weight Assessment and Counseling for Nutrition and Physical Activity for Children and Adolescents – BMI CMS155v2 0024
Weight Assessment and Counseling for Nutrition and Physical Activity for Children and Adolescents – Counseling for Nutrition CMS155v2 0024
Weight Assessment and Counseling for Nutrition and Physical Activity for Children and Adolescents – Counseling for Physical Activity CMS155v2 0024
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention CMS138v2 0028
Breast Cancer Screening CMS125v2 0031
Cervical Cancer Screening CMS124v2 0032
Chlamydia Screening for Women CMS153v2 0033
Colorectal Cancer Screening CMS130v2 0034
Use of Appropriate Medications for Asthma CMS126v2 0036
Childhood Immunization Status CMS117v2 0038
Preventive Care and Screening: Influenza Immunization CMS147v2 0041
Pneumonia Vaccination Status for Older Adults CMS127v2 0043
Diabetes: Eye Exam CMS131v2 0055
Diabetes: Foot Exam CMS123v2 0056
Diabetes: A1c > 9 CMS122v2 0059
Diabetes: Hemoglobin A1c Test for Pediatric Patients CMS148v2 0060
Diabetes: Urine Protein Screening CMS134v2 0062
Diabetes: Low Density Lipoprotein (LDL) Management CMS163v2 0064
Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic CMS164v2 0068
Ischemic Vascular Disease (IVD): Complete Lipid Panel CMS182v3 0075
Ischemic Vascular Disease (IVD): LDL Control CMS182v3 0075
HIV/AIDS: Medical Visit CMS62v2 0403
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up: >= 65 Years CMS69v2 0421
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up: 18 – 64 Years CMS69v2 0421
Hypertension: Improvement in Blood Pressure CMS65v3 N/A
Primary Caries Prevention Intervention as Offered by Primary Care Providers, including Dentists CMS74v3 N/A
Children Who Have Dental Decay or Cavities CMS75v2 N/A
HIV/AIDS: RNA Control for Patients with HIV CMS77v2 N/A

 

Meaningful Use - General Practice CQMs

 

Copyright 2014 © Azara Healthcare